cost effectiveness Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing The partners will also collaborate on a study, to be peer reviewed, that will evaluate how insurance coverage of WGS affects patient care and healthcare costs. Agendia's MammaPrint Breast Cancer Risk Test Cost-Effective in Multi-Country Analysis Using MammaPrint to guide breast cancer chemo de-escalation could result in significant healthcare savings in five of six evaluated countries, according to the analysis. Cascade Testing for Dilated Cardiomyopathy Likely to Be Cost Effective, Analysis Finds An Australian team developed a decision model for testing asymptomatic relatives of patients with dilated cardiomyopathy to assess the cost effectiveness of testing. Preventive Genomic Screening of Young Adults Could be Cost-Effective, Australian Research Suggests An Australian research team found that population genetic screening for hereditary cancer and for carrier status could be cost-effective. PGx Utility, Cost Effectiveness Touted at AMP, Countering FDA Message on Evidence Premium At a Thermo Fisher-sponsored workshop, two companies argued for the clinical utility of PGx LDTs as FDA prepared to issue a warning against unapproved tests. Aug 27, 2018 Rapid Molecular TB Testing Reduces Patient Isolation, Saves Hospitals Money, Study Shows May 22, 2018 Genomind Adds Utility Evidence for Mental Illness PGx Test in Bid to Increase Payor Acceptance Premium May 16, 2018 Early Sequencing in Infants With Suspected Mendelian Disorders May Save Money May 10, 2018 Zika Screening of Individual Blood Donations Costs $5M for Every Positive Result, Study Shows Mar 22, 2018 MedSeq Study Finds Whole-Genome Sequencing Does Not Increase Medical Costs in Short Term Feb 7, 2018 Qiagen, Sentieon Extend Data-Analysis Partnership to Clinical Genomics Premium Mar 7, 2017 Personalized Medicine Growing, Though Challenges Remain Nov 12, 2016 At AMP Meeting, T2 Reports Annual Cost Saving of Up to $3M for Hospital Using Rapid Sepsis MDx Premium Jun 27, 2016 Precision Lung Cancer Drugs on Pricing Evaluation Group's Agenda Premium Apr 20, 2016 AMP Publishes Economic Analysis of Genomic Sequencing Procedures to Support Lab, Payor Discussions Mar 16, 2016 Managing Genetic Tests Can Prevent Misorders, Avoid Costs, Stanford Study Shows Feb 5, 2016 Dutch Study Finds Exome Sequencing Could Cut Costs for Dx in Children With Intellectual Disability Feb 1, 2016 Good Start Genetics, Evidera Publish Data Demonstrating Cost Effectiveness of NGS Carrier Screening Aug 27, 2015 In Medicare Population, Oncotype DX Linked to Less Chemo in High-Risk Patients, More in Low-Risk Premium Jul 8, 2015 New Analysis Examines Financial Impact of Genotyping Patients to Guide Anti-Platelet Therapy Premium Feb 5, 2015 UK's NHS Adopts NICE Advice to Provide Oncotype DX for Intermediate Risk Breast Cancer Patients Dec 3, 2014 Myriad Reports Abstracts on Cost-Effectiveness, Clinical Utility of Prolaris Nov 20, 2014 NHS Cancer Drug Fund Reevaluating Whether to Keep Providing Several Pricey Personalized Therapies Premium Nov 28, 2012 Study Finds KRAS Testing in Metastatic CRC Saves Money, but Questions Value of EGFR Inhibitors Premium Nov 7, 2012 UnitedHealthcare Sees Need for National Registry to Track Use, Set Coverage of Molecular Tests Premium Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.